| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |